Article
A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Molecular pharmaceutics - 1 Jan 2000
Kim Insook, Song Xueqin, Vig Balvinder S, Mittal Sachin, Shin Ho-Chul, Lorenzi Philip J, Amidon Gordon L
Abstract excerpt
Biphenyl hydrolase-like protein (BPHL, NCBI accession number NP_004323) is a novel human serine hydrolase recently identified as a human valacyclovirase, catalyzing the hydrolytic activation of the antiviral prodrugs valacyclovir and valganciclovir. The substrate specificity of BPHL was investigated with a series of amino acid ester prodrugs of the therapeutic nucleoside analogues: acyclovir, zidovudine,...
Topics
- Acyclovir
- Amino Acid Sequence
- Antiviral Agents
- Carboxylic Ester Hydrolases
- Cloning, Molecular
- Drug Design
- Enzyme Activation
- Escherichia coli
- Ganciclovir
- Genetic Variation
- Humans
